{name}
{subtitle}
A Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression
city
~51 mi. (McAllen, Texas, +160 more cities)
facility
USOR: Texas Oncology - McAllen South Second
condition
Fallopian Tube Carcinoma, +2 more conditions
drug type
chemotherapy, +1 more type
Study of Sacituzumab Govitecan-hziy (SG) Versus Docetaxel in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Progression on or After Platinum-Based Chemotherapy and Anti-programmed Death Protein 1 (PD-1)/Programmed Death Ligand 1 (PD-L1) Immunotherapy
city
~51 mi. (McAllen, Texas, +17 more cities)
facility
Texas Oncology Cancer Care and Research Center
drug type
chemotherapy, +1 more type
A Study Evaluating the Efficacy and Safety of Inavolisib + Palbociclib + Fulvestrant vs Placebo + Palbociclib + Fulvestrant in Patients With PIK3CA-Mutant, Hormone Receptor-Positive, Her2-Negative, Locally Advanced or Metastatic Breast Cancer
city
~51 mi. (McAllen, Texas, +186 more cities)
facility
Texas Oncology, P.A. - McAllen; South Texas Cancer Center-McAllen
biomarker
ER Positive, +3 more biomarkers
drug
fulvestrant, +2 more drugs
drug type
hormone therapy, +1 more type
Study of CBP501/Cisplatin/Nivolumab Combinations in Advanced Pancreatic Cancer
city
~51 mi. (McAllen, Texas, +13 more cities)
facility
Texas Oncology, P.A. (McAllen)
drug
CBP501, +2 more drugs
drug type
chemotherapy, +2 more types
A Study to Compare the Efficacy and Safety of a Combined Regimen of Venetoclax and Obinutuzumab Versus Fludarabine, Cyclophosphamide, and Rituximab (FCR)/ Bendamustine And Rituximab (BR) in FIT Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL) Without DEL (17P) or TP53 Mutation
city
~51 mi. (McAllen, Texas, +50 more cities)
facility
South Texas Cancer Center - McAllen
drug
obinutuzumab, +1 more drug
drug type
chemotherapy, +1 more type